Provided by Tiger Fintech (Singapore) Pte. Ltd.

Brickell Biotech, Inc.

2.35
0.0000
Volume:- -
Turnover:72.15K
Market Cap:7.05M
PE:-0.19
High:2.35
Open:2.35
Low:2.35
Close:2.35
Loading ...

Company Profile

Company Name:
Brickell Biotech, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on identifying, developing, and commercializing various prescription therapeutics for the treatment of debilitating skin diseases in the United States. The company's lead product candidate is sofpironium bromide that is in phase 3 clinical trial to treat patients with primary axillary hyperhidrosis. It has a collaboration agreement with AnGes, Inc. for the development of a novel DNA vaccine candidate for COVID-19. The company was founded in 2009 and is headquartered in Boulder, Colorado.